Experts Support DNA Sequencing in All Newborns
Many rare disease experts agree that DNA sequencing to screen for treatable childhood disorders should be made available to all newborns.
Read MorePosted by Melanie Hamilton-Basich | May 12, 2023 | Molecular Diagnostics |
Many rare disease experts agree that DNA sequencing to screen for treatable childhood disorders should be made available to all newborns.
Read MorePosted by Chris Wolski | May 11, 2023 | Urinalysis & Toxicology |
Parkway Clinical Laboratories Inc. (PCL), has launched Xylazine testing via LCMSMS confirmation testing on urine specimens.
Read MorePosted by Melanie Hamilton-Basich | May 10, 2023 | Diagnostic Technologies |
A team developed a simple nomogram based on easily accessible and automatable detected routine clinical indicators to reduce missed diagnosis and misdiagnosis of Wilson’s disease.
Read MorePosted by Chris Wolski | May 9, 2023 | Company News |
Revvity, Inc. officially launches today as a science-based solutions company that leverages innovation across life sciences and diagnostics.
Read MorePosted by Chris Wolski | May 9, 2023 | Covid 19, Molecular Diagnostics, POC Rapid Assays |
The expiration of the federal Public Health Emergency for COVID-19 provides new impetus for lab innovation in the post-pandemic world.
Read More